The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality

OBJECTIVE: To compare the risk of mortality among men treated for benign prostatic hyperplasia (BPH) with 5 alpha-reductase inhibitors (5ARI) to those treated with alpha-blockers (AB) in community practice settings. METHODS: We employed a retrospective matched cohort study in 4 regions of an integra...

詳細記述

保存先:
書誌詳細
出版年:Urology
主要な著者: Wallner, Lauren P., DiBello, Julia R., Li, Bonnie H., Van Den Eeden, Stephen K., Weinmann, Sheila, Ritzwoller, Debra P., Abell, Jill E., D’Agostino, Ralph, Loo, Ronald K., Aaronson, David S., Horwitz, Ralph I., Jacobsen, Steven J.
フォーマット: Artigo
言語:Inglês
出版事項: 2018
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8080272/
https://ncbi.nlm.nih.gov/pubmed/29906480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urology.2018.05.033
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料